|
|
(5) ¿ÍÀÎÀå ¿ù³Ó
|
|
 |
EHiSqVRsgeDDorAQop |
 |
396 |
|
 |
| Your cash is being counted http://boobs.pet/ cartoon boobs For Biogen's two older MS drugs, second-quarter sales rose 2 percent to $774 million for Avonex and fell 2 percent to $387 million for Tysabri. Its share of sales of the cancer drug Rituxan for the quarter was $289 million. |
 |
 |
Rhett |
 |
2019-09-17 14:04:14 |
|
|
|
|
|
|
|
|
|